GlassScriptPhysician profile
Elexander N Atkinson
NPI 1831718204
$2,209.72
in general payments reported to CMS, 2019-2025
16 companies · $1,225 in 2025
The $1,225 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.90 · 2021: $153 · 2022: $632 · 2023: $168 · 2024: $17.81 · 2025: $1,225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,411.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $498.23 | 2020-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $345.53 | 2022-2025 | Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.16 | 2021-2023 | Spiriva Respimat, Jardiance |
| Pfizer INC. | $244.24 | 2021-2025 | |
| Axsome Therapeutics, INC. | $207.18 | 2025 | Symbravo |
| Abbvie INC. | $201.22 | 2022-2025 | Teflaro |
| Gilead Sciences, INC. | $169.25 | 2025 | Yeztugo |
| Lilly USA, LLC | $75.48 | 2021-2022 | |
| Amgen INC. | $34.37 | 2025 | Repatha |
| Paratek Pharmaceuticals, INC. | $33.18 | 2023 | Nuzyra |
| Daiichi Sankyo INC. | $32.68 | 2021-2022 | |
| Dexcom, INC. | $29.66 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.48 | 2023 | Lifevest |
| Hologic Sales and Service, LLC | $25.38 | 2025 | Thinprep 2000 Processor, Aptima |
| Exact Sciences Corporation | $17.14 | 2023 | Cologuard Collection Kit |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elexander Atkinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.